文献速递淋巴瘤

肿瘤抑制性TGF-β/SMAD1/S1PR2信号轴在弥漫性大B细胞淋巴瘤中反复失活

The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma.
PubMed 文献 · Blood · 2018-04-03

本研究探讨S1PR2上游调控机制,发现TGF-β/TGF-βR2/SMAD1轴通过磷酸化SMAD1直接结合S1PR2基因座调控其转录。CRISPR编辑S1PR2、SMAD1或TGFBR2使DLBCL细胞对TGF-β诱导的凋亡无反应,缺失任一因子在体外及多种小鼠移植模型中均获生长优势。小鼠S1pr2缺失致生发中心B细胞过度增殖并加速MYC驱动淋巴瘤发生,Tgfbr2缺失可模拟该表型;>85%的DLBCL患者SMAD1表达异常下调。

要点

  • TGF-β/TGF-βR2/SMAD1轴通过磷酸化SMAD1直接结合S1PR2调控元件激活其转录。
  • CRISPR编辑S1PR2、SMAD1或TGFBR2使DLBCL细胞对TGF-β诱导的凋亡无反应。
  • >85%的DLBCL患者SMAD1表达异常下调,提示该轴在DLBCL中反复失活。

核心结论

  • TGF-β/TGF-βR2/SMAD1/S1PR2轴在DLBCL中具有重要肿瘤抑制功能,DLBCL细胞通过下调SMAD1表达使该通路失活。

研究设计与样本

  • 研究采用DLBCL细胞系、CRISPR基因组编辑、染色质免疫沉淀、皮下异种移植模型、MISTRG小鼠脾和骨髓原位生长模型、免疫小鼠及自发和连续移植模型。

主要发现

  • 磷酸化SMAD1直接结合S1PR2基因座调控元件(染色质免疫沉淀证实)。
  • CRISPR编辑S1PR2、SMAD1或TGFBR2的DLBCL细胞对TGF-β诱导的凋亡无反应。
  • 缺失S1PR2、SMAD1或TGFBR2任一因子的DLBCL克隆在体外、皮下异种移植及MISTRG小鼠脾和骨髓原位模型中均具有明显生长优势。
  • S1pr2缺失诱导免疫小鼠生发中心B细胞过度增殖,并在自发和连续移植模型中加速MYC驱动淋巴瘤发生。
  • 小鼠生发中心B细胞特异性Tgfbr2缺失可模拟S1pr2缺失对生发中心B细胞过度增殖的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The sphingosine-1-phosphate receptor S1PR2 and its downstream signaling pathway are commonly silenced in diffuse large B-cell lymphoma (DLBCL), either by mutational inactivation or through negative regulation by the oncogenic transcription factor FOXP1. In this study, we examined the upstream regulators of S1PR2 expression and have newly identified the transforming growth factor-β (TGF-β)/TGF-βR2/SMAD1 axis as critically involved in S1PR2 transcriptional activation. Phosphorylated SMAD1 directly binds to regulatory elements in the S1PR2 locus as assessed by chromatin immunoprecipitation, and the CRISPR-mediated genomic editing of S1PR2, SMAD1, or TGFBR2 in DLBCL cell lines renders cells unresponsive to TGF-β-induced apoptosis. DLBCL clones lacking any 1 of the 3 factors have a clear growth advantage in vitro, as well as in subcutaneous xenotransplantation models, and in a novel model of orthotopic growth of DLBCL cells in the spleens and bone marrow of MISTRG mice expressing various human cytokines. The loss of S1pr2 induces hyperproliferation of the germinal center (GC) B-cell compartment of immunized mice and accelerates MYC-driven lymphomagenesis in spontaneous and serial transplantation models. The specific loss of Tgfbr2 in murine GC B-cell phenocopies the effects of S1pr2 loss on GC B-cell hyperproliferation. Finally, we show that SMAD1 expression is aberrantly downregulated in >85% of analyzed DLBCL patients. The combined results uncover an important novel tumor suppressive function of the TGF-β/TGF-βR2/SMAD1/S1PR2 axis in DLBCL, and show that DLBCL cells have evolved to inactivate the pathway at the level of SMAD1 expression.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Stelling A, Hashwah H, Bertram K, et al. The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma. Blood. 2018. PMID: 29615404. doi:10.1182/blood-2017-10-810630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。